Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Breast cancer
Jul 22, 2024, 23:08 | Blog
Yuksel Urun: Breast cancer risk factors strongest evidence
Yuksel Urun shared on X: ''Breast Cancer Risk Factors. Strongest evidence for: parity, age at first…
Jul 22, 2024, 20:26 | Insight
How tumor biology impacts Patritumab deruxtecan's efficacy in early breast cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, posted on X: "Our colleague Aleix Prat's…
Jul 21, 2024, 21:49 | Blog
Dose-Dense vs Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X, about a recent paper…
Jul 21, 2024, 20:01 | Insight
Optimal Anastrozole Dose for Estrogen Suppression in Postmenopausal Breast Cancer
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, shared on LinkedIn a recent…
Jul 21, 2024, 16:03 | Blog
Maria Ansari: I want to recognize Brooke Vuong on her appointment to the CDC’s Advisory Committee on Breast Cancer in Young Women
Maria Ansari, CEO and Executive Director at The Permanente Medical Group, shared a post on…
Jul 21, 2024, 11:12 | Blog
Rebecca Shatsky: Current standards and future goals for systemic therapy in breast cancer
Rebecca Shatsky shared on X: "Easier access to our paper on current standards and future goals…
Jul 21, 2024, 09:09 | Blog
MASCC webinar on Precision Medicine for Hormone Receptor Positive Breast Cancer
MASCC shared on X:        . "Reminder! Join us on July 29 for…
Jul 20, 2024, 17:44 | Insight
Piotr Wysocki: Who should not get dose-dense adjuvant chemotherapy in breast cancer?
Piotr Wysocki recently posted on LinkedIn: "For many years, dose-dense adjuvant chemotherapy has been considered the…
Jul 20, 2024, 10:37 | Blog
Personalized Dose-Dense Adjuvant Chemotherapy for High-Risk Early breast cancer
Ivan R. Gonzalez, Medical Oncologist at Comprehensive Oncology Center, Hospital Angeles Puebla, shared a post…
Jul 19, 2024, 13:45 | Insight
Homologous recombination deficient breast cancer are more sensitive to chemo-radiotherapy
Memorial Sloan Kettering Radiation Oncology shared on X about a recent paper titled "Increased synthetic…
All: 2990 Posts: 401 - 410
Special Coverage